Baxter Recalls Cefazolin Injection Bags Due to Particulate Matter
Baxter Healthcare is recalling 19,032 bags of Cefazolin Injection due to the presence of particulate matter. The affected product is distributed nationwide in the US.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of at least 4 per the rubric. The presence of particulate matter in an intravenous injection poses a significant risk of harm.
Plain-English summary
Baxter Healthcare Corporation is recalling 19,032 bags of Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag. The recall is being conducted because of the presence of particulate matter in the product. The affected product is identified by Lot # LD175708 with an expiration date of 14-Feb-2027.
The recalled product is a sterile, frozen premix infusion bag manufactured by Baxter Healthcare Corporation in Deerfield, IL. It is distributed nationwide in the United States. The product is a prescription-only medication intended for intravenous use.
Healthcare providers and patients should stop using the affected product immediately. Consumers should check their inventory for the specific lot number and expiration date listed above. If the product is found, it should be returned to the distributor or manufacturer according to standard recall procedures.
The recalled product
- Product
- CEFAZOLIN (CEFAZOLIN SODIUM)
- Brand
- CEFAZOLIN
- Manufacturer
- Baxter Healthcare Corporation
- Category
- Drug — Antibiotic Injection
- Affected units
- 19,032
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # LD175708
- Exp Date: 14-Feb-2027.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CEFAZOLIN
- SevereSandoz cefazolin cartons contained vials labeled as penicillin G potassium
FDA (Drugs) · 2025-07-09
- ModerateCardinal Health Recalls Cefazolin Injection Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
Same manufacturer · Baxter Healthcare Corporation
See all →- HighBaxter Duo-Vent Solution Set Recalled for Air Bubbles in Tubing
FDA (Devices) · 2026-08-19
- SevereHillrom VOLARA System patient circuits recalled for nebulizer cup leakage
FDA (Devices) · 2026-07-08
- HighBaxter Head Positioning Adapter May Loosen During Patient Positioning
FDA (Devices) · 2026-07-08
- SevereHillrom VOLARA System patient circuits recalled for nebulizer leakage risk
FDA (Devices) · 2026-07-08
- SevereHillrom VOLARA P.CIRCUIT Medical Device Nebulizer Cup Leakage Recall
FDA (Devices) · 2026-07-08
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereAmerican Regent Recalls Atropine Sulfate Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereFDA Recalls Nicardipine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Multrys Trace Elements Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26